Published in
Oxford University Press, The Oncologist, 3(20), p. e5-e5, 2015
DOI: 10.1634/theoncologist.2014-423
Links
- ORCID
- Oxford University Press | PDF
- ORCID
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
- [europepmc.org] | PDF
Tools
In Reply
Journal article published in 2015 by
Dario Baratti 
,
Filippo de Braud,
Shigeki Kusamura,
Claudia Maggi,
Filippo Braud,
Marcello Deraco ,
Maria Di Bartolomeo ,
Filippo Pietrantonio
,
Filippo de Braud,
Shigeki Kusamura,
Claudia Maggi,
Filippo Braud,
Marcello Deraco ,
Maria Di Bartolomeo ,
Filippo Pietrantonio
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The authors are currently conducting molecular and genetic research to identify new targets for therapeutic interventions and predictive biomarkers in pseudomyxoma peritonei. The final aim of these studies is to rationalize the choice of treatment, which remains an unmet clinical need.